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Abstract: Trehalose (α-D-glucopyranosyl α-D-glucopyranoside) is a non-reducing sugar 
with unique stabilizing properties due to its symmetrical, low energy structure consisting of 
two 1,1-anomerically bound glucose moieties. Many applications of this beneficial sugar 
have been reported in the novel food (nutricals), medical, pharmaceutical and cosmetic 
industries. Trehalose analogues, like lactotrehalose (α-D-glucopyranosyl α-D-galactopyranoside) 
or galactotrehalose (α-D-galactopyranosyl α-D-galactopyranoside), offer similar benefits as 
trehalose, but show additional features such as prebiotic or low-calorie sweetener due to 
their resistance against hydrolysis during digestion. Unfortunately, large-scale chemical 
production processes for trehalose analogues are not readily available at the moment due to 
the lack of efficient synthesis methods. Most of the procedures reported in literature suffer 
from low yields, elevated costs and are far from environmentally friendly. “Greener” alternatives 
found in the biocatalysis field, including galactosidases, trehalose phosphorylases and 
TreT-type trehalose synthases are suggested as primary candidates for trehalose analogue 
production instead. Significant progress has been made in the last decade to turn these into 
highly efficient biocatalysts and to broaden the variety of useful donor and acceptor sugars. 
In this review, we aim to provide an overview of the latest insights and future perspectives 
in trehalose analogue chemistry, applications and production pathways with emphasis  
on biocatalysis. 
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1. Introduction 
Trehalose (α-D-glucopyranosyl α-D-glucopyranoside or α,α-trehalose) is a non-reducing disaccharide 
that consists of two 1,1-linked α-glucose monosaccharides (Figure 1a) and possesses interesting 
properties for the food and pharmaceutical industry [1]. In nature, it is present as osmolyte in a wide 
range of organisms, most notably yeasts and plants, where it protects the host against environmental 
stresses. In addition, trehalose is also stable at a wide range of pH-values, has a mild sweet taste and is 
not cariogenic. These features make it ideally suited for use in processed food, where trehalose is now 
even the “functional oligosaccharide” with the highest market share [2]. The downside is that ingested 
trehalose also contributes to the caloric intake as it can be efficiently hydrolysed in the small intestine 
by trehalases (α,α-trehalose-1-C-glucohydrolase, EC (Enzyme Commission) number 3.2.1.28), present 
in the intestinal villi, and then absorbed in the form of glucose [3]. 
 
Figure 1. Structure of trehalose (a) and its analogues lactotrehalose (b); galactotrehalose (c); 
and 6-azidotrehalose (d). The azide-functional group is indicated in red. 
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Analogues of trehalose containing other carbohydrate moieties besides glucose are believed to  
have a more beneficial metabolic profile. For example, lactotrehalose (α-D-galactopyranosyl  
α-D-glucopyranoside), where the first glucose unit has been replaced by galactose (Figure 1b), is not  
a substrate for intestinal trehalase but functions as a competitive inhibitor of the same enzyme [4]. 
Consequently, this disaccharide does not contribute to the energy content of food preparations and at 
the same time also lowers the metabolic conversion of trehalose. A crucial factor is that it still offers 
the same stabilizing properties as trehalose by virtue of the non-reducing α-(1,1)-α linkage [5]. 
In addition to their benefits for the food industry, trehalose analogues also show properties that are 
of interest to the pharmaceutical field. As trehalose is, unlike in humans, an essential metabolite for 
Mycobacteria, deoxy- or azido-derivatives of trehalose (Figure 1d) form valuable tools to inhibit 
mycobacterial cell growth or for future imaging and detection of Mycobacterium tuberculosis, the 
causative agent of tuberculosis [6]. 
Despite their value, analogues of trehalose have not yet been studied very extensively because no 
cost-effective process for their large-scale synthesis is currently available. In industry, trehalose is 
produced from starch through a two-step enzymatic process that makes use of the consecutive action of 
a transglycosidase and a glycosidase [7]. Since this basically comes down to the rearrangement of 
glucose molecules, other types of monosaccharides cannot be incorporated through this process. 
Therefore, alternative production routes for trehalose analogues have recently been explored, which 
will be extensively discussed and compared in this review. 
2. Trehalose and Its Analogues: Diversity, Function and Applications 
Trehalose, a known osmolyte, is relatively widespread in nature as it can be found in the  
nucleocytosolic compartment of bacteria, yeasts, fungi, insects, invertebrate animals and plants,  
but is absent in higher vertebrates. Naturally occurring trehalose analogues, or more specifically  
trehalose-based oligosaccharides, are less prevalent with few compounds reported in bacteria,  
mostly in Mycobacteria, and very recently in the ascospores of the fungus Neosartorya fischeri [8].  
A galactose-containing analogue was found in Mycobacterium smegmatis, whereas  
mannopyranosyl-substituted trehaloses were isolated from Mycobacterium bovis BCG [9]. Two  
amino-analogues, namely GlcNAc-α-(1,1)-α-Glc and GlcNAc-α-(1,1)-α-Man, can be produced by 
certain strains of Streptomyces and possess antibiotic activity [10,11]. Ascospores of Neosartorya fischeri 
contain a series of trehalose-based tri-, tetra- and pentaoligosaccharides, of which the latter two, named 
neosartose and fischerose, respectively, have not been reported before in nature [8]. 
Trehalose is a versatile component that fulfills diverse biochemical functions ranging from  
carbon or energy source (glucose release upon hydrolysis), signaling molecule, component of cell wall 
glycolipids to, most importantly, protecting agent against various environmental stress conditions, 
including heat, freezing, reactive oxygen species and drought [12]. When faced with stress, trehalose 
gradually accumulates inside the cytoplasm of the organism as direct response where it prevents 
macromolecules from denaturing and, in addition, suppresses their aggregation [13]. These stabilizing 
effects of trehalose on cells and macromolecules (proteins, membranes,) have mainly been attributed to 
the clam shell conformation in which axial-axial-linked α-(1,1)-α disaccharides crystallize [5]. Other 
saccharides that crystallize in an axial-equatorial fashion, like α,β-trehalose or in a more open 
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conformation, like sucrose, maltose and lactose, do not exert such beneficial stabilization properties.  
It is believed that trehalose analogues, however, should possess the same stabilizing properties of 
trehalose as this 1,1-linkage in an axial-axial fashion, claimed to be the key for anhydrobiotic preservation, 
is retained here. This proved to be the case for α,α-galactotrehalose (α-D-galactopyranosyl  
α-D-galactopyranoside) (Figure 1c), albeit to a smaller extent than trehalose [5]. In addition, both 
trehalose and its analogues are non-reducing disaccharides and as such do not engage in Maillard 
reactions. Trehalose itself is also remarkably stable in a wide pH range (between 3.5 and 10) and at 
high temperatures (up to 120 °C for 90 min) [1]. Its strong resistance to hydrolysis can be explained  
by the remarkably low energy content of its glycosidic bond (1 kcal/mol), when compared to that of 
sucrose (27 kcal/mol), for example [14]. Due to this reason, trehalose analogues are expected to 
possess similar resistance properties. 
Thanks to its stability-enhancing features, trehalose is useful for various applications in the fields of 
food production, cosmetics and pharmaceuticals. It is present in many natural food products and 
received the GRAS (Generally Recognized As Safe) status as food additive in the year 2000. It has a 
less pronounced (only 45% relative sweetness) but longer lasting sweetness than sucrose [15], and can 
suppress the bitterness or enhance sourness of food [16]. Interestingly, trehalose also inhibits lipid 
oxidation by heating and exposure to air [1], thus increasing shelf-life and minimizing the release of 
unpleasant odors. The addition of trehalose prior to drying of fruits or vegetables prevents 
discoloration and stabilizes their aroma [17,18]. Despite its food stabilizing benefits, trehalose is prone 
to enzymatic digestion in the human gut and as such contributes to the caloric intake. Lactotrehalose 
(α-D-glucopyranosyl α-D-galactopyranoside), in contrast, cannot be hydrolyzed by trehalase and even 
showed to competitively inhibit this enzyme and other intestinal brush-border disaccharidases from rat, 
including sucrase, maltase and isomaltase [4]. This interesting observation opens up a myriad of 
possible applications, the most obvious one being the use as a low-calorie sweetener, suitable for 
consumption by diabetic patients. In addition, higher systemic concentrations of lactotrehalose can be reached 
upon oral ingestion, which should allow this analogue to outperform trehalose in therapeutic applications. 
Furthermore, as lactotrehalose is not hydrolyzed in the intestines, it reaches the colon in an intact 
state where it could exert prebiotic properties. Indeed, di-, tri- or tetrasaccharides containing  
α-galactosyl, α-glucosyl and α-fructosyl residues are known to selectively stimulate the growth of 
health-promoting bifidobacteria [19]. Biochemical or medicinal interest may arise from the  
α-galactoside epitope, which is widely expressed in mammalian tissues in the form of the cell surface 
glycolipids or glycoproteins [20]. This epitope induces specific transfer of drugs towards the liver. 
Recently, lactotrehalose was proposed as a molecular mimic of globosyl (Gb) disaccharide [21]. 
Lactotrehalose could in this case be used to create compounds with certain beneficial properties. For 
example, conjugation of lactotrehalose to a Gb3 ceramide-mimetic polymer allowed detoxification and 
neutralization of Shiga-toxin, the major virulence factor of enterohemorrhagic E. coli (EHEC), which 
leads to severe symptoms and even death upon infection [20,22]. The inhibition of trehalase makes this 
compound also an interesting target for the development of environmentally friendly insecticides, as 
trehalose is the vital energy source for the flight of insects [23]. 
Finally, trehalose analogues form valuable tools for probing of Mycobacteria via their trehalose 
metabolism and as potent inhibitors of mycobacterial growth [6]. These types of organisms rely on 
trehalose as precursor for essential cell wall glycolipids and other metabolites [24]. In the past, the 
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trehalose metabolism was found to be related to the virulence of pathogenic mycobacteria, including 
Mycobacterium tuberculosis, the causative agent of tuberculosis [25]. Trehalose analogues chemically 
modified with fluorescent detectable tags, like fluorescein and azide, were successfully applied for 
detection and imaging of living Mycobacteria [6,26]. This observation is exciting as it paves the 
pathway for future application of tagged trehalose analogues in tuberculosis diagnostics. Furthermore, 
some trehalose analogues disrupt essential metabolic pathways and as such offer potential as 
antimycobacterial compounds [27,28]. For example, 6-azido-6-deoxy-α,α′-trehalose (Figure 1d) has  
the capacity to interfere with cell wall synthesis of Mycobacterium aurum and in this way inhibits  
its growth and survival [29]. Other unnatural analogues like trehalose mono-esters possess 
immunoregulatory properties [30], which render them very useful as adjuvant in vaccine development 
against tuberculosis [31]. An overview of the most valuable applications of trehalose and its analogues is 
provided in Figure 2. 
 
Figure 2. Summary of applications for trehalose and its analogues in food, pharmaceutical, 
cosmetics and agricultural industries. 
3. Biocatalytic Synthesis Routes for Trehalose Analogues 
The interest in trehalose analogue synthesis arose in the 1970s, when the first chemical [32]  
and enzymatic [33] procedures were published, with even new developments being reported up  
to date [20,34]. In general, trehalose analogues are difficult to produce via chemical methods as these 
struggle to obtain C2-symmetry or to achieve a strict α-(1,1)-α anomeric control. Although some 
purely chemical methods have been developed for trehalose desymmetrization or for manipulation  
of regioselective hydroxyl-groups, these are usually lengthy, inefficient and low-yielding [9]. 
Furthermore, the use of heavy metal catalysts and solvents in chemical synthesis is less desirable for an 
end product that is expected to be used as food additive. A more “ecological” or “greener” alternative 
in the form of enzymatic synthesis reactions is thus highly anticipated. To that end, inspiration can be 
drawn from the biocatalytic synthesis of trehalose, a topic that has been studied quite intensively 
during the last decades [35–38]. So far, five main pathways have been described in literature for the 
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biocatalytic production of trehalose (see Figure 3). The traditional and most widespread production 
method consists of two consecutive enzyme-catalyzed steps via trehalose-6-phosphate synthase (TPS, 
EC 2.4.1.15) and trehalose-6-phosphate phosphatase (TPP, EC 3.1.3.12) starting from uridine 
diphosphate (UDP)-glucose and glucose-6-phosphate with intermediary trehalose-6-phosphate 
formation (Figure 3a) [37]. Later on, also the malto-oligosyltrehalose synthase (MTS, EC 
5.4.99.15)/malto-oligosyltrehalose hydrolase (MTH, EC 3.2.1.141) system generating trehalose out  
of starch [7,39] (Figure 3b) and the TreS-type trehalose synthase (EC 5.4.99.16) catalyzing the 
intramolecular rearrangement of maltose (α-(1,4) bond) to trehalose (α-(1,1) bond) [40,41] (Figure 3c), 
were acknowledged as alternative, highly efficient trehalose production systems. 
 
Figure 3. Schematic representation of biocatalytic pathways for trehalose synthesis.  
The traditional trehalose phosphate synthase/phosphorylase (TPS/TPP) route (a); the  
malto-oligosyltrehalose synthase/hydrolase (MTS/MTH)-coupled route (b); the TreS-type 
trehalose synthase route (c); the TreT-like trehalose synthase route (d); and the inverting 
(e) or retaining (f) trehalose phosphorylase (TP) routes coupled with other glycoside 
phosphorylases, i.e., maltose phosphorylase (MP) and sucrose phosphorylase (SP), 
respectively. The latter three pathways (d–f) are also amenable to trehalose analogue synthesis. 
NDP = nucleoside diphosphate. 
Out of these pathways, only the routes using inverting or retaining trehalose phosphorylases  
(TP) [33,42] (Figure 3e,f) and TreT-type trehalose synthases (Figure 3d) [34,43] can be easily adapted 
towards biocatalytic trehalose analogue synthesis. A third possible enzymatic pathway for analogues 
production, not applicable for trehalose synthesis, makes use of galactosidases [44,45]. Each of these 
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three routes comes with its own advantages and disadvantages, inherent to the respective enzyme class 
employed, on which will be further elaborated in this review. 
3.1. Galactosidase-Catalyzed Production 
Galactosidases were the first enzymes ever to be exploited for the synthesis of trehalose di- or 
trisaccharide analogues. In 1995, a thermostable α-galactosidase (EC 3.2.1.22) from Candida guilliermondii 
was reported to generate galactotrehalose through reverse hydrolysis when high concentrations of 
galactose were used as substrate [44]. Unfortunately, the enzyme was not very selective and preferably 
formed a 1,6-linkage, with 1,3- and 1,2-isomers being formed as well. Later on, an E. coli  
β-galactosidase (EC 3.2.1.23) was used for the conversion of trehalose into trisaccharides via a 
transgalactosylation reaction [45]. In addition to hydrolyzing lactose, the latter enzyme was also able 
to catalyze the transfer of a β-galactosyl group from lactose to the 4′- as well as the 6′-position of one 
of the glucose moieties, yielding a mixture of 4′- and 6′-β-D-galactopyranosyl trehalose (Figure 4). 
 
Figure 4. Pathway for synthesis of trehalose trisaccharide analogues via E. coli  
β-galactosidase activity starting from the disaccharides lactose and trehalose. 
Both types of galactosidases clearly suffer from one of the typical drawbacks when using  
hydrolases for synthetic purposes, i.e., low regioselectivity. In case the acceptor contains more than 
one hydroxyl-group, a mixture of products is formed, which is difficult to separate and significantly 
complicates downstream processing [46]. Another drawback is their low product yield, although this 
could be improved by controlling the reaction kinetically or thermodynamically [47]. 
3.2. TreT-Type Trehalose Synthase-Catalyzed Production 
The TreT-type trehalose synthase (EC 2.4.1.245) catalyzes the production of trehalose from  
nucleoside diphosphate (NDP)-activated glucose, preferably UDP-glucose, as donor and D-glucose as 
acceptor (Figure 5a). It belongs to the class of “Leloir” glycosyltransferases, more specifically the 
GlycosylTransferase family 4 (GT4), known for their strict regioselectivity and high product yields [48]. 
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TreT is a rather “young” specificity first discovered ten years ago in the hyperthermophilic archeae 
Pyrococcus horikoshii [49]. Since then, the enzyme has been identified in many other 
hyperthermophilic organisms, including Thermococcus litoralis [50], Thermoproteus tenax [51] and 
Thermotoga maritima [34]. These TreTs all possess an excellent thermostability, an exceptional 
feature that makes them highly applicable for industrial synthesis reactions that need to be performed 
at elevated temperatures to prevent batch contaminations. 
 
Figure 5. TreT-type trehalose synthase. (a) Natural reaction in trehalose synthesis 
direction starting from UDP-glucose and D-glucose; (b) active site residues (indicated in 
dark purple) surrounding the D-glucose moiety (light blue) in the acceptor binding pocket of 
P. horikoshii TreT [49]. Replacing the histidine at position 92 into an alanine via  
site-specific mutagenesis resulted in a 10% improvement of the activity on mannose as 
alternative acceptor monosaccharide. 
The TreTs from these organisms all have a broad acceptor monosaccharide specificity in common, 
turning them into interesting tools for analogues production [34,42]. For example, wild-type  
P. horikoshii TreT shows excellent activity on the alternative acceptors D-galactose (90%), D-mannose 
(80%) and even D-fructose (20%) in addition to the natural acceptor D-glucose. The wild-type  
T. maritima TreT, in turn, showed 70% and 35% conversion of D-mannose and D-fructose, 
respectively, into the corresponding trehalose analogues [7]. Furthermore, the acceptor promiscuity 
naturally present in these types of enzymes is prone to further enhancement via enzyme engineering. 
The activity on D-mannose of the P. horikoshii TreT could be improved to 90% by replacing the 
histidine residue at position 92 in the acceptor-binding pocket by an alanine via site-specific 
mutagenesis [49] (Figure 5b). Theoretically, it should therefore be feasible to produce a broad variety 
of trehalose analogues from the respective monosaccharide and NDP-glucose with other natural or 
engineered TreTs. 
Recently, Urbanek and coworkers [6] exploited the potential of combining chemical synthesis with 
TreT-catalyzed synthesis as alternative pathway for trehalose analogue production. With the 
promiscuous TreT from T. tenax, they managed to synthesize a broad variety of trehalose analogues  
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with high yields (up to 99%) starting from chemically synthesized glucose analogues, bearing fluoro-, 
deoxy-, thio- and azido-modifications. With some further process optimization and scale-up, this 
combinatorial approach has the potential to provide easy access to a variety of novel trehalose 
analogues on industrial scale. 
The major drawback of analogues production via “Leloir” glycosyltransferases, however, is their  
need for expensive nucleotide-activated donor substrates, like UDP-glucose or UDP-galactose.  
To overcome this price burden, one-pot biocatalytic systems were developed that can ensure a 
continuous recycling of the donor substrate in situ through coupling with sucrose synthase or  
UDP-glucose-4′-epimerase [52,53]. In the past, similar coupling systems also proved very effective in 
enhancing glycosylation yields by other Leloir glycosyltransferases [54,55]. 
3.3. Inverting Trehalose Phosphorylase-Catalyzed Production 
A third option for trehalose analogue synthesis relies on the enzymatic activity of trehalose 
phosphorylases (TP), present in several bacteria, yeasts and fungi. TPs catalyze the reversible 
phosphorolysis of trehalose to D-glucose-1-phosphate (Glc-1P) and D-glucose [56]. As the former 
product possesses a high energy content, the reaction can be efficiently reversed for the synthesis of 
trehalose and its analogues. From all known phosphorylase specificities to date, TP is the only one that 
has evolved independently into two mechanistically different classes, i.e., retaining or inverting 
enzymes, leading to the formation of either α- or β-Glc-1P, respectively (Figure 3e,f). 
So far, most of the work has been done with inverting TPs (EC 2.4.1.64), which belong to the  
Glycoside Hydrolase family 65 (GH65), along with maltose and kojibiose phosphorylase as other 
important members. This specificity was first discovered in the algae Euglena gracilis [57] and has 
since then been reported in both fungi and bacteria, including Micrococcus varians [58], 
Thermoanaerobacter brockii [59], Bacillus stearothermophilus [60], Paenibacillus [61] and 
Caldanaerobacter subterraneus [62]. In addition, a BlastP search revealed the presence of homologous 
genes in a broad range of other bacteria from a variety of phyla including Proteobacteria, 
Actinobacteria, Bacteroidetes, Firmicutes, Cyanobacteria and Green sulfur bacteria [63]. Similar to the 
TreT-type synthases, the inverting TPs from B. stearothermophilus, T. brockii and C. subterraneus were 
also found to be thermostable with activity optima around 75, 70 and 80 °C, respectively [60,62,64]. 
The inverting TPs from T. brockii [42] and C. subterraneus [62] were found to be quite 
promiscuous for their acceptor substrate, showing activity towards a broad range of monosaccharides 
including D-galactose, D-xylose, D-fucose, D-mannose, aminosugars, L-sugars like L-arabinose and  
L-fucose, and 1,6-linked disaccharides like melibiose or gentiobiose [42,62]. Therefore, these enzymes 
form useful biocatalysts for the synthesis of a variety of trehalose analogues [42] or novel non-reducing 
derivatives like 6-O-α-D-galactopyranosyl trehalose [59]. Such promiscuity is not common in all 
inverting TPs. The first discovered TP from Euglena gracilis shows a much stricter acceptor 
specificity with only 6-deoxyglucose and D-xylose as allowed substitute monosaccharides for  
D-glucose [65]. 
Similar as for the TreT-type trehalose synthases, the acceptor specificity of TPs can be enhanced via 
enzyme engineering. Recently, an efficient process was reported for the synthesis of lactotrehalose  
from galactose and β-Glc-1P that relied on an engineered T. brockii TP variant with improved 
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galactose specificity (Figure 6) [66]. By random mutagenesis, an R448S mutant was generated with a 
two- to three-fold lower Km-value for galactose and an improved catalytic efficiency for mannose  
and fructose. The latter observation ultimately suggests some involvement of the mutation in  
acceptor specificity. 
 
Figure 6. Enhancing acceptor and donor specificity of T. brockii trehalose phosphorylases 
(TP) and C. subterraneus TP via random mutagenesis and rational design, respectively.  
(a) Reversible conversions of β-Glc-1P with D-galactose and β-Gal-1P with D-glucose into 
lactotrehalose, catalyzed by the T. brockii TP-single mutant (R448S) with enhanced 
acceptor specificity, and the C. subterraneus TP-triple mutant (L694G/A693Q/W371Y) 
with enhanced donor specificity, respectively; (b) Active sites of T. brockii TP (left) and  
C. subterraneus TP (right) with the positions subjected to mutagenesis indicated. For  
T. brockii TP, the mutated R448-residue is shown in orange/blue amongst other mutated 
residues from the same study, and the trehalose substrate with the catalytic residue (E498) 
in green. In the C. subterraneus TP active site, the three mutagenized positions 
(L694G/A693Q/W371Y) causing a switch in donor specificity are indicated in green with 
the corresponding wild-type residues shown in yellow. The lactotrehalose substrate is 
indicated in orange [66,67]. 
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In addition to focusing on the acceptor flexibility, engineering the donor specificity of an inverted 
TP could further extend the pool of trehalose analogues that could be produced with these enzymes. To 
give an idea of the potential, the donor specificity of the C. subterraneus TP could be modified 
towards β-Gal-1P by introducing three mutations (L694G/A693Q/W371Y), identified through iterative 
saturation (Figure 6) [67]. The triple mutant displayed a 10-fold improved catalytic efficiency on the 
alternative donor substrate, and could thus be used for the synthesis of lactotrehalose, with D-glucose 
as acceptor, and even galactotrehalose, with D-galactose as acceptor. Interestingly, the combined action  
of the T. brockii and the C. subterraneus variants can also be used for the net phosphorylation of  
D-galactose, which then enters such a two-step process from the acceptor side, but leaves from the 
donor side with lactotrehalose as intermediate (Figure 6) [67]. 
3.4. Retaining Trehalose Phosphorylase-Catalyzed Production 
The main factor hindering the economic exploitation of inverting TPs for synthetic purposes is the 
high price of their glycosyl donor β-Glc-1P, i.e., about $60 per mg. Moreover, it is not available in 
large amounts [68]. In contrast, α-Glc-1P is more than 2000 times cheaper (about $25 per g) and, 
additionally, is more amenable to large-scale production [46]. That is why, lately, interest in retaining 
TPs (EC 2.4.1.231) as potential alternatives for analogues production has increased. Retaining TPs are 
the only glycoside phosphorylases classified within a glycosyltransferase family, i.e., GT4-family, and 
their mechanism is still a matter of debate [69]. They are mainly found in the mycelium or fruit body 
of fungi such as Agaricus bisporus [70], Schizophyllum commune [71] or Grifola frondosa [72]. In 
general, retaining TPs are quite specific for α-Glc-1P and D-glucose in the synthesis direction and for 
trehalose in the breakdown direction [71,72]. Enhancing their acceptor and donor specificity via 
enzyme engineering is therefore desired to broaden the spectrum of trehalose analogues that could be 
produced. In a preliminary study, the wild-type G. frondosa TP already showed minor activity on  
D-mannose (around 3%) as alternative acceptor substrate [73], suggesting a potential for future 
improvement of its acceptor specificity via rational design. 
At the moment, however, the retaining TPs poor stability and expression yields are major hurdles 
that slow down engineering efforts and, consequently, their potential industrial application. For 
example, G. frondosa TP is stable up to 32.5 °C in the trehalose synthesis direction with activities that 
rapidly decrease at higher temperatures [74]. Incubation at 37 °C for 15 min in the absence of 
stabilizing substrates almost completely inactivates this enzyme with less than 4% residual activity  
left [73]. The purified S. commune enzyme even loses activity within a few hours when kept at 4 °C in a 
buffered saline solution [75]. Despite the marked stabilization effect, employing glycerol as protectant 
during storage could be questioned as even small amounts (10% to 20% (w/v)) of this compound 
induce TP-inhibition [76]. These hurdles need to be overcome in the future in order for effective 
industrial synthesis with retaining TPs to become feasible. 
4. Conclusions, Outlook and Future Perspectives 
It is clear that the functional oligosaccharide market has shown an impressive growth recently, not 
least due to the success of trehalose. As new production methods have reduced its price almost a  
100-fold, myriad applications in food, biotechnological, pharmaceutical and cosmetic could be 
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developed. Analogues of this compound are even more promising as it is very likely that they retain 
their stabilizing properties, and offer some additional benefits. Trehalose analogues might be interesting as 
low-calorie prebiotic compounds or therapeutic compounds able to reach higher systemic concentrations. 
This review aimed to compare different enzymatic routes towards the trehalose analogue synthesis, 
of which trehalose phosphorylases and TreT-type trehalose synthases are the most promising.  
A combination of “smart” in silico based enzyme engineering to further change the specificity of  
these biocatalysts towards alternative donor or acceptor molecules and reaction engineering should 
eventually result in an industrially viable production process. Optimizing synthetic processes via 
coupling of reactions catalyzed by natural or engineered biocatalysts could allow for recycling of 
glycosyl donors, resulting in cost-effective and high-yielding analogues production. Indeed, α-Glc-1P 
can be synthesized from sucrose and starch by sucrose phosphorylase (EC 2.4.1.7) or maltodextrin 
phosphorylase (EC 2.4.1.1), whereas β-Glc-1P can be generated from maltose by maltose 
phosphorylase (EC 2.4.1.8). By combining one of these activities with trehalose phosphorylase in a 
one-pot setup, trehalose analogues can be synthesized in a very cost-effective way from cheap and 
abundantly available substrates with in situ phosphate-recycling [38,74]. 
Finally, it should be noted that the enzymatic conversion is only part of the story, since the 
downstream processing of the corresponding reaction mixtures is also a major challenge. To date, 
activated carbon and ion-exchange chromatography have been proposed for that purpose [42,77], but 
both methods suffer from scalability issues or elevated operational costs, prohibiting the scale-up of 
analogues purification. It is clear that the way forward in cost-effective biocatalytic production of 
trehalose analogues consist of the integration of enzyme and process engineering, not only aiming for 
the most efficient biocatalyst but also for more practical and operational procedures. 
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